Eric Swayze, EVP, Research at IONIS PHARMACEUTICALS INC (IONS), sold 195 shares at $55.99 ($11K) on 2021-01-05, disclosed to the SEC on 2021-01-06.
Scheduled sale ($11k) by EVP, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |